Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NSF attachment protein gamma (NAPG) is a cytoplasmic protein essential for vesicular trafficking and membrane fusion, where it functions as a member of the soluble NSF attachment protein (SNAP) family[1][2][3][4]. It enables the N-ethylmaleimide-sensitive fusion protein (NSF) to bind to membranes, stabilizing complexes involved in vesicular transport, particularly between the endoplasmic reticulum and the Golgi apparatus, and plays a role in platelet exocytosis[1][2][3]. NAPG is implicated in regulating SNARE complex assembly and disassembly, fundamental for intracellular membrane fusion events. Genetic studies suggest a possible association between NAPG polymorphisms and bipolar disorder, and disease links have been reported to epilepsy and other neuropsychiatric conditions[1][5]. No drugs are currently known to specifically target this protein, and it is not classified as a canonical therapeutic target in pharmacology[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NSF attachment protein gamma (NAPG).